Atlas Trials

Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers

Clinical trial NCT00169000 · COMPLETED

Trial details

NCT number
NCT00169000
Sponsor
Dartmouth-Hitchcock Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2003-01-01
Primary completion
2005-09-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.